Literature DB >> 27194676

Paraneoplastic cerebellar degeneration as a marker of endometrial cancer recurrence.

Geoffrey Lie1, Thomas Morley1, Muhammad Chowdhury2.   

Abstract

An 84-year-old woman developed a cerebellar syndrome having undergone a total abdominal hysterectomy and bilateral salpingo-oophorectomy for endometrial cancer 1 year previously. She was found to be anti-Yo antibody positive and was diagnosed with paraneoplastic cerebellar degeneration (PCD). A subsequent positron emission tomography scan and lymph node biopsy identified recurrence of her endometrial cancer. This case illustrates how PCD can be an indicator of cancer recurrence, underlines the significance of PCD as a prompt to search for underlying malignancy, and highlights the difficulties PCD poses to the clinician in terms of diagnosis and management. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 27194676      PMCID： PMC4885438          DOI： 10.1136/bcr-2016-215286

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

1.  Clinical insights into paraneoplastic cerebellar degeneration.

Authors:  R Scheid; R Voltz; S Briest; R Kluge; D Y von Cramon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

2.  Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Authors:  I Rojas; F Graus; F Keime-Guibert; R Reñé; J Y Delattre; J M Ramón; J Dalmau; J B Posner
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

3.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

4.  Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.

Authors:  Ozgur Tanriverdi; Nezih Meydan; Sabri Barutca; Nazan Ozsan; Duygu Gurel; Ali Veral
Journal:  Jpn J Clin Oncol       Date:  2013-03-08       Impact factor: 3.019

5.  Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.

Authors:  K Peterson; M K Rosenblum; H Kotanides; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

6.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

7.  Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.

Authors:  Antonio Santillan; Robert E Bristow
Journal:  Nat Clin Pract Oncol       Date:  2006-02

8.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

Review 9.  Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.

Authors:  Peter Widdess-Walsh; Jinny O Tavee; Stephan Schuele; Glen H Stevens
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130
  9 in total
  1 in total

Review 1.  Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature.

Authors:  Michalis Liontos; Oraianthi Fiste; Danai Drakopoulou; Nikolaos Thomakos; Kalliroi Goula; Flora Zagouri; Maria Anagnostouli; Meletios-Athanasios Dimopoulos
Journal:  Gynecol Oncol Rep       Date:  2021-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.